National Reye's Syndrome Foundation
Requests that FDA-mandated labeling for products containing aspirin be extended to all salicylate-containing products. "Too many cases of Reye's Syndrome have suspiciously been linked to one product in particular, [Procter & Gamble's] Pepto-Bismol, to account for it being coincidental," Chicago Chapter President Carolyn Jender maintained in a recent letter to FDA. The foundation believes that 20%-25% of Reye's Syndrome reported cases are the result of salicylate-containing products.
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”